Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBioingénierie tissulaire [BIOTIS]
dc.contributor.authorNAVEAU, Adrien
dc.contributor.authorKRET, Marion
dc.contributor.authorPLAIRE, Valerie
dc.contributor.authorDELORME, Olivier
dc.contributor.authorMARCHI, Sebastien
dc.contributor.authorDE BATAILLE, Caroline
dc.contributor.authorDESTRUHAUT, Florent
dc.contributor.authorARRIVE, Elise
dc.contributor.authorBOU, Christophe
dc.date.accessioned2023-02-21T13:34:19Z
dc.date.available2023-02-21T13:34:19Z
dc.date.issued2022-03-18
dc.identifier.issn1745-6215en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/172021
dc.description.abstractEnSoft palate defects created during oral cancer surgery may prevent complete palatal closure and trigger palatopharyngeal insufficiency. One current treatment employs a rigid obturator prosthesis; an extension of acrylic resin at the level of the hard palate ensures surface contact with the remaining musculature. Unfortunately, airflow escape often causes hypernasality, compromises speech intelligibility, and creates swallowing problems (including leakage of food and fluid into the nasal airway). We plan to test a new removable denture featuring a thick dental dam that serves as a membrane obturator. The principal objective of the clinical trial is a comparison of speech handicap levels after 1 month in patients with acquired velar insufficiencies who wear either the new device or a conventional, rigid obturator. The secondary objectives are between-device comparisons of the swallowing handicaps and the health-related qualities of life.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enDeglutition disorder
dc.subject.enMaxillofacial prosthesis
dc.subject.enMouth neoplasm
dc.subject.enPalatal obturator
dc.subject.enProsthodontics
dc.subject.enRandomized controlled trial
dc.subject.enSpeech disorder
dc.subject.enVelopharyngeal insufficiency
dc.title.enEfficacy of a new membrane obturator prosthesis in terms of speech, swallowing, and the quality of life of patients with acquired soft palate defects: study protocol of the VELOMEMBRANE randomized crossover trial
dc.title.alternativeTrialsen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s13063-022-06163-6en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
bordeaux.journalTrialsen_US
bordeaux.volume23en_US
bordeaux.hal.laboratoriesBioingénierie Tissulaire (BioTis) - U1026en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionCHU de Bordeauxen_US
bordeaux.institutionInstitut Bergoniéen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03999041
hal.version1
hal.date.transferred2023-02-21T13:34:24Z
hal.exporttrue
dc.rights.ccCC BYen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Trials&rft.date=2022-03-18&rft.volume=23&rft.issue=1&rft.eissn=1745-6215&rft.issn=1745-6215&rft.au=NAVEAU,%20Adrien&KRET,%20Marion&PLAIRE,%20Valerie&DELORME,%20Olivier&MARCHI,%20Sebastien&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée